Decitabine and SAHA-Induced Apoptosis Is Accompanied by Survivin Downregulation and Potentiated by ATRA in p53-Deficient Cells
Expression of Bcl-2, survivin, and p21WAF1 in HL-60 cells after 48 h of ATRA and/or DAC + SAHA treatment. (a) Transcription levels monitored by qRT-PCR. (b) Protein expression monitored by immunoblotting. Error bars represent ±SEM of three measurements. (c) Representative immunoblots with β-actin expression as a loading control.